Added to FLCCC protocols and Fareed-Tyson protocol among others. It was tested in. Design thinking was supposed to fix the world. People who report not tolerating the drug are typically prescribed too high a dose. But a panel of key opinion leaders from the NIH, CDC . With little government funding available for such work, Kirsch founded the Covid-19 Early Treatment Fund (CETF), putting in $1 million of his own money and bringing in donations from Silicon Valley luminaries: the CETF website lists the foundations of Marc Benioff and Elon Musk as donors. Tech millionaire Steve Kirsch went from covid trial funder to and increased heart rate (which could be nerves about the dilated pupils). Here are the key things you should know about fluvoxamine for COVID: It works. Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI), a class of anti-depressants, mostly prescribed for people suffering from an obsessive-compulsive disorder. Im just telling you the truth. Things took a final and dramatic turn once Kirsch started claiming the government was covering up vaccine deaths. 533. By Steve Kirsch in fluvoxamine Feb 14, 2021 The case for fluvoxamine for treating COVID-19 A very short op-ed arguing for using fluvoxamine against COVID. The only way to do that is to treat them as early as possible with a drug that prevents hospitalization and death. We pretty much practice government agency opinion medicine all over the world now, with just a few exceptions. of the 'intellectual dark web '" and allowed him to access a "large and receptive audience to his claims about a fluvoxamine conspiracy". Since making a fortune as the founder of Infoseek, an early search engine that was the Google of its day, Kirsch has spent tens of millions of dollars fighting humanitys biggest threats. Generally, at 50mg BID x 14, it is very tolerable as long as the patient is instructed to lay off the caffeine. He felt like he in good conscience had to speak out about covid, and so he made the decision to separate himself from M10, says Char, who has known Kirsch since the 1980s. He thinks # killed by vax could be anywhere between 0 and 150K people dead.. Please read and agree to the disclaimer before watching this video.. Steve Kirsch On COVID Early Treatment and CensorshipSteve Kirsch is an entrepreneur and . . Thats pretty typical, but your mileage may vary. The NIH picks the drug that makes the most money for the drug companies regardless of long-term safety Molnupiravir! Tech Entrepreneur Crusades for SSRI as COVID Therapy We report a real-world experience using fluvoxamine for coronavirus disease 19 (COVID-19) in a prospective cohort in the setting of a mass outbreak. The drug was FDA-approved more than 65 years ago. . Eventually, a press representative who was listening in, David Satterfield, unmuted his microphone to suggest we finish our conversation by email. New evidence that toxic "spike protein" component of Covid-19 vaccines Is that really true? Im taking low dosage Fluvoxamine as part of a multi-drug FLCCC protocol to alleviate some mild brain fog. Author Affiliations Article Information. The data is there in plain sight for anyone to see today. I was just getting tired, he said, before asking to speak off the record. Its sad, but its true, he told me. So check the side-effects list to be familiar with which side-effects are associated with which drug so if you have a side-effect, youll know which drug to reduce or eliminate. The NIH did nothing despite the fact the that NIH, FDA, CDC, and academic institutions participated in the panel, this is NOT about the science. The NIH Guidelines committee is being very slow to react (we have no idea if they are even considering the drug because nobody is allowed to know that because all their deliberations are kept secret). While YouTube has repeatedly taken down the full video of the DarkHorse episode, various clips have been watched over 4 million times, and the full audio remains available on Spotify. NIH is still unsure whether fluvoxamine should be used to treat COVID. Fluoxetine is just as effective. Thats why they didnt change their recommendation when the Phase 3 trial was published in Lancet. Note that a total of 77 people got the drug, not 65. If you ask your doctor for any evidence that fluvoxamine doesnt work or is harmful (like a DB-RCT which is the only thing they trust), they will show you nothing. Steve Kirsch Home page Also, for people who cant tolerate fluvoxamine for whatever reason (nausea, jittery, etc), this is the alternative. Silence from the medical community. Some people report mild nausea while on the drug (stops when stop the drug). I mean, he really, truly has a heart of gold, Char told me. Reason is the hospital gets release from liability if they follow NIH guidelines. But fear of trying something new prevents any doctor from giving this drug a try. (PDF) Kaplan Textbook of Psychiatry JL copy - Academia.edu - Share research Kirsch, despite having direct access to the actual trial runner, eventually became convinced a correct interpretation of the data would show that hydroxychloroquine worked. Some people are jittery, but usually that is because the doctor either prescribed a dosage higher than 50mg twice a day or didnt notify the patient to. It does not matter how many lives will be saved. While combining the results of several well-designed trials can strengthen an argument or unearth patterns unseen in smaller samples, a meta-analysis is just the sum of its parts; any single well-done experiment is more useful than combining the results of several poorly done ones. Other SSRIs work as well, but fluvoxamine activates the Sigma-1 receptor the most of the SSRIs which is why it was chosen. vocus It is an amazing drug and is a very simple safe way to avoid long-haul COVID symptoms. We are ignoring the advice of the KOL group and doing nothing. Medicine isnt about saving lives anymore. 33. The track management was so impressed, they asked for prescriptions. Adverse reactions/side effects. Enter the email address you signed up with and we'll email you a reset link. Be warned!. But the whole process has gone too slowly for Kirsch. Molnupiravir followed patients for only 30 days because they know the drug is dangerous. Fluvoxamine is also an committee votes 11-2 that the evidence is not adequate to demonstrate a net health benefit for molnupiravir over symptomatic care alone; Paxlovid and fluvoxamine receive more favorable votes, This site requires JavaScript to run correctly. Steve Kirsch: NIH and WHO COVID-19 Treatment Guidelines Are Too If you cant get a prescription for COVID, then perhaps you have OCD? At the end of May this year, Siliciano emailed the other advisors to say that Kirsch had gone off the deep end and he was cutting ties. The FDA approved Molnupiravir which was less effective. I fully expected both organizations to do absolutely nothing. Then he hosted a superspreader event. Early treatment with existing drugs is the fastest, most effective, and lowest. If you ask your doctor for any evidence that fluvoxamine doesnt work or is harmful (like a DB-RCT which is the only thing they trust), they will show you nothing. All the medical journals refused to publish the meeting notes (rejected by 6 journals). Share this post. You cannot get any better than that. Steve Kirsch is a high-tech serial entrepreneur based in Silicon Valley. Online Status. Fluvoxamine To Treat COVID: what you need to know - CoronaFraud.com Paper reviewing the evidence and mechanisms of action for fluvoxamine: Lenze Phase 2 RCT published Nov 12, 2020: Seftel RWE trial that confirmed the Phase 2 trial published Feb 1, 2021. Expert Panel Discussion on COVID-19 and Medical Freedom Their willingness to lie did. He has been a medical philanthropist for more than 20 years. There were no studies reported out so far where fluvoxamine made things worse or neutral. . We didnt come up with better mouse technology than Microsoft did. Skirsch.io Steve Kirsch Home page Fluvoxamine, COVID, pandemic, . This document is a collection of evidence that highlights the glaring errors in our pandemic response. Incriminating evidence - Steve Kirsch's newsletter - Substack His foundation shifted focus to one goalcuring Steve Kirschby supporting one of the few scientists looking at the disease. Steve Kirsch: $25,000 to Anyone that Proves Fluvoxamine - TrialSiteNews 22, 2021, 9:00 a.m. Steve Kirsch , a former tech entrepreneur who earned a fortune worth up to $300 million, has been showcased on TrialSite a few times for his activity supporting the clinical development of repurposed drugs for COVID-19 treatments. This is a more comprehensive look at the key evidence supporting fluvoxamine: Hear from the doctors who did the studies directly as well as the Dean of Medicine at Emory University: List of the best evidence-based COVID treatment options. Online Status. Government agencies are ignoring the science. Hes very convincing. But Kirsch is also motivated by an unsatisfied competitive streak. Steve Kirsch's Newsletter ^ | 02/26/22 | Steve Kirsch. It is about following orders and making money for the drug companies and protecting the doctor from liability and losing his medical license. For example, tylenol+caffeine+fluvoxamine can lead to serotonin syndrome. Some countries dont have fluvoxamine so this is the alternative. YouTube , , , fluvoxamine, , , , , , , , , , Steve Kirsch Nov 5, 2021 145 92 Here are the key things you should know about fluvoxamine for COVID: It works. The most stunning study of fluvoxamine ever done was at the Golden Gate Fields racetrack in November 2020, right after the WashU trial was published in JAMA. Its not about the science. Early research suggests that fluvoxamine, an FDA approved medication for depression and obsessive compulsive disorder, can be an effective early treatment for COVID-19. We now have a viable solution to reduce COVID hospitalization and mortality; Say you just got diagnosed with COVID. Steve calls himself a "medical philanthropist" who says "the most important thing to me is saving lives." In . So why would we wait when lives are being lost? Medicine has been transformed to doing whatever the NIH/FDA says, regardless of how many lives will be lost. If you take fluvoxamine, please avoid caffeine while on the drug. Its motivated out of his sense of keeping people safe and advancing health care.. If you start later, doctors use higher dosages and compliance becomes a bigger problem. He started 7 high tech companies, two with billion dollar market caps. . The group who declined the drug were very sick with 12.5% requiring hospitalization and one died. Fluvoxamine has at least a 30% hospitalization and death benefit. 90,000 people don't have to die in the next 3 weeks. Lack of action. Fluvoxamine is a very safe drug on market for 37 years, tens of millions of people have taken it, no record in scientific literature of anyone dying on overdose, and according to doctors that know the drug the best, about as dangerous as taking a Tylenol. The incident, he added, was completely in keeping with his personality.. The NIH picks the drug that makes the most money for the drug companies regardless of long-term safety Molnupiravir! It is currently approved for treatment of depression and obsessive compulsive disorder (OCD). The drugs mechanisms of action were explained to the KOL panel which voted 2>1 in favor of fluvoxamine. Here is what, e) which concluded: Under a variety of assumptions, fluvoxamine shows a high probability of preventing hospitalization in outpatients with COVID-19., For more about fluvoxamine (and other SSRIs that work), see, fluvoxamine completed a Phase 3 study showing it works that was published in the Lancet Global Health, NIH basically dismissed the fluvoxamine study as I predicted they would, few people werent afraid of expressing their displeasure, the highly acclaimed Bangladesh mask study showed, Johns Hopkins has incorporated fluvoxamine in their treatment guidelines, Ontario has become the first province to list fluvoxamine as a treatment doctors can consider for patients. Medicine today isnt about saving your life. While Kirsch had the final say in who received grants, no one I spoke with expressed concerns about what projects had been funded, or why. So much for evidence-based medicine. I fully expected both organizations to do absolutely nothing. Medium revoked my account for life. It was 25 years ago yesterday that Andrew Wakefield launched the modern iteration of the antivaccine movement.In doing so, he laid down a template that antivax quacks today still follow. The WashU Phase 3 study hasnt been disclosed yet, but they had compliance problems with their patients this time around (phase 2 was local so the patients got the drug early and also were very compliant and the placebo group was truly taking nothing). Do the NIH and WHO COVID treatment recommendations need to be fixed? just like ivermectin). After I ended the Zoom meeting, Satterfield called me to apologize for cutting us off. That was a lie. So when a group of scientists applied for an EUA for fluvoxamine, what did the FDA do? Other SSRIs work as well, but fluvoxamine activates the Sigma-1 receptor the most of the SSRIs which is why it was chosen. An approach that promised to democratize design may have done the opposite. Dosing. There are 4 outpatient studies that have been done (2 at WashU (see. Infoseek lost out to Yahoo; it had a chance to grow bigger, but it didn't. How I recommend people treat COVID and the fascinating backstory of how fluvoxamine was discovered. Three of the four outpatient trials have been reported out: all were successful. The trials that were abandoned for futility werent getting events because the patients were given standard of care meds. What has alarmed many of the scientists associated with CETF, though, are Kirschs reactions to the work hes fundedboth successes and failures. Fluvoxamine (Luvox) is a Selective Serotonin Receptor Inhibitor (SSRI) that is clinically indicated for OCD in children, and can be used off label for depression. Kirsch is a serial entrepreneur who has spent decades pitching the next big thing, whether optical mice (Mouse Systems), document processing (FrameMaker), search engines (Infoseek), digital. (One of them, Eric Lenze, was in fact giving a presentation on fluvoxamine to the National Institutes of Health the next day.) 36m "We found Fauci was the most highly compensated federal employee. See this Wall Street Journal op-ed. $1M reward: Do we need more data re: Fluvoxamine for COVID-19? thinks it should be used (and that the NIH is wrong for waiting for more clinical trials). By Steve Kirsch Mar 14, 2021 Fluvoxamine, Proxalutamide, and Ivermectin: 100% success I'm very bullish on two drug combos since it is rare for a single drug to be 100% successful. About - vacsafety.org Summarizes the 5 observational studies, RCT, RWE, and some of the more interesting anecdotal data. See this. Steve Kirsch is a Silicon Valley philanthropist. NIH and WHO refuse to acknowledge it works since it will cause vaccine hesitancy if it is known that there is a drug that turns COVID into a mild disease. This is what the Seftel trial at Golden Gate fields used. Steve put in $1MM of his own money and . This is why Cliff doesnt talk to me. Ms Tech | Pexels (hands); Kirsch (skirsch.com), Ivermectin has been falsely promoted as a covid treatmentbut for those who use the drug legitimately, seeing it become a piece of anti-vaccine misinformation is disconcerting, supports Technology Review's reporting on covid, anti-covid-vaccine, pro-ivermectin pundit, Roomba testers feel misled after intimate images ended up on Facebook, How Rust went from a side project to the worlds most-loved programming language. If the drug is started right after symptoms, weve seen 100% prevention in hospitalization. Fluvoxamine, COVID, pandemic, . It used to be that a Phase 3 study would do it. Fluvoxamine: The evidence - Steve Kirsch Home page Nobody who took the drug got sick at all, most all wanted to return to work within 3 days after starting treatment. Fluvoxamine, Proxalutamide, and Ivermectin: 100% success Since FLV is a safe drug, it should have been widely discussed with patients that there is virtually no downside and a huge reduction in hospitalization if the drug is given early. The Lancet paper showed that if you were treated early enough and took the drug as prescribed (it only works if you take it), it was shown to reduce your chance of death by 12X making it far more effective than any other drug for COVID. So it was both obvious and convincing the difference between the groups to the workers and the track management. Do they sell it anywhere? The ICER independent review showed fluvoxamine is more effective than Molnupiravir: Read this article I wrote about using fluvoxamine correctly for COVID. If you start 5 days after symptoms, all bets are off. Other drugs in this class include Prozac (fluoxetine), Zoloft (sertraline) and Paxil (paroxetine). National Patterns in Antidepressant Medication Treatment - Home of JAMA At the beginning of the COVID-19 pandemic, Steve Kirsch created the COVID-19 Early Treatment Fund (CETF) to finance trials of off-patent drugs in an attempt to find a potent treatment that had been staring us in the face. The NIH wrote a bullshit rejection because the FDA told them not to approve it. Were having trouble saving your preferences. This post was written to memorialize the corruption. It is in a class of drugs known as selective serotonin-reuptake inhibitors (SSRIs), but unlike other SSRIs, fluvoxamine interacts strongly with a protein called the sigma-1 receptor. To protect M10 from my COVID-19 vaccination opinions, I will no longer post about my vaccination concerns here.. Molnupiravir followed patients for only 30 days because they know the drug is dangerous. As trial results rolled in, that mismatch began to put a strain on Kirschs relationship with the funds advisory board. . ALWAYS check with your doctor and report any medications you are taking before or plan to take after you start taking fluvoxamine. CETF founder Steve Kirsch accepted an invitation to discuss the findings on a weekly . Fluvoxamine for early treatment of covid-19 - Medical Update Online It could do nothing. So the drug had no chance of working (since there were no events), so the trial was stopped for futility, NOT because the drug doesnt work. I've collected fluvoxamine evidence here for convenient access. Entrepreneur Steve Kirsch who holds an early patent for the optical mouse decided to get involved in treating Covid. Summary of key evidence. In California, Silicon Valley tech entrepreneur Steve Kirsch was also thinking about the pandemic. In the second trial, it was shown to be 100% effective in long-haul COVID symptoms: None of the treated patients had any long-haul symptoms after 2 weeks compared to 60% of untreated patients having 1 or more of the 15 long-haul symptoms after two weeks, and 29% having 4 of more of the long haul symptoms after 2 weeks. That is when the phase 2 results were published. By Steve Kirsch Last updated: March 14, 2021 After I appeared on the60 Mi nut es story about fluvoxamine,I've received a lot of questions from people about how to treat COVID. In 2013, Johnson & Johnson paid $2.2 billion for its own kickback and fraud scandal, including a specific $400 million fine for its subsidiary Janssen, which manufactures the covid vaccine. Don't underestimate the virus. Fluvoxamine for COVID: what you need to know - Substack Thats pretty typical, but your mileage may vary. The study was also featured on 60 Minutes. Hes also made several videos and podcasts with Vladimir Zelenko, the conspiracy theorist doctor who convinced Trump to take hydroxychloroquine. Im sorry to sound so cynical. My website www.skirsch.io has tons of info on fluvoxamine with all the links. Antidepressant fluvoxamine could keep mild COVID-19 from worsening How covid-19 conspiracy videos keep getting millions of views. Has it really been 25 years, a whole quarter of a century? He pushes fluvoxamine, an anti-depression drug which despite doing very well in covid treatment studies has been strangely neglected. In other cases, stop cold turkey. But not 150K. @stkirsch. Get your prescription in advance of getting COVID. Here are my answers. Author Affiliations . This should be top news, but the press is ignoring this and attempt to write stories about it are killed by the editors. And FrameMaker is still a niche product. Online. The reason that it isnt used is because the medical community ignores evidence-based medicine principles. That way you can start immediately. Soon after his appearance on the DarkHorse podcast, several partners of his most recent startup, M10, expressed concerns about the increasing extremism of Kirschs vaccine views. Hes refused to accept the results of a hydroxychloroquine trial that showed the drug had no value in treating covid, for instance, instead blaming investigators for poor study design and statistical errors. MisinformationKills. No one has been able to come up with an example where phase 2 + this level of evidence resulted in a failure of Phase 3. Kirsch and his wife, Michele, fund a charitable foundation, which by 2007 had given $75 million to different causes. The NIH did nothing despite the fact the that NIH, FDA, CDC, and academic institutions participated in the panel. An MIT Technology Review investigation recently revealed how images of a minor and a tester on the toilet ended up on social media. He has a history of giving away some of his millions to good causes, and when COVID-19 began. There are 4 outpatient studies that have been done (2 at WashU (see Phase 2 trial results published in JAMA), one in Berkeley, CA by David Seftel, one in Brazil published in the Lancet, and one in-patient study done in Croatia. There are reports of people who cant tolerate the drug, but they stop using it and nothing bad happened. To scientists, giving fluvoxamine a chance means running a large trialnot giving it to individual patients in the clinic, off-label and outside the context of active data collection and analysis. Or just depression about the vaccine mandates? All this was known back in January 2021 when a key opinion leader panel of experts from NIH, CDC, FDA, academia, and journal editors voted by over 2:1 to recommend that fluvoxamine be recommended to physicians to discuss with patients. P-value was 10^-14 on that study (done by Dr. Seftel). including the very promising Fluvoxamine. I wanted to get the article out before my flight left. Sage Hana. My website. She understands complex, politicized pandemicsshe was one of the first clinicians to specialize in HIV/AIDS, and she sat on the FDA advisory panel that approved the first antiretroviral drug. Why the FDA should grant an EUA for fluvoxamine immediately, Links to evidence about fluvoxamine including the public data repository, Here's the first one: They knew in advance it was coming and on the day the paper was published they ignored it entirely. In other cases, stop cold turkey. Those days are gone. Doctors have no excuse for not prescribing. Completely avoid caffeine, alcohol, tylenol, and benadryl. Decreasing the dosage or stopping the medication will mitigate symptoms within hours. To protect M10 from my COVID-19 vaccination opinions, I will no longer post about my vaccination concerns here. Steve Kirsch is an inventor of the optimal mouse, a Silicon Valley millionaire, and an MIT alum (Class of '80). On January 22, 2021, thirty key opinion leaders (KOL) from NIH, CDC, and leading academic institutions met to review the evidence for using fluvoxamine for treating COVID. Proxalutamide and fluvoxamine pushers and the early treatment grift. May 16, 2022. Perhaps Kirschs most effective tactic, though, is simply his willingness to outlast everyone else. Some speaker, off camera, went on a . Even though an expert panel was overwhelmingly convinced in just one hour, hearing a very small subset of all the supporting evidence, the organizations that they belong to are taking their time. Physicians who use the drug for COVID now swear by it. Discover special offers, top stories, upcoming events, and more. At that dose, no side effects were reported for his patients (I know of only one person who had mild nausea at that dose) and everyone reversed out their symptoms in an average of 3 days. Fluvoxamine is an inexpensive drug that has been in use for 37 years and has been used by an estimated 10 million people. Tech millionaire Steve Kirsch went from covid trial funder to If you have trouble getting a prescription, perhaps you have OCD? ICER: Please, As of November 13, fluvoxamine has been proven to work in every trial that has published results, including, studies. Los Altos Hills resident Steve Kirsch funded research into the drug fluvoxamine as a treatment for COVID-19. One is to reduce the threat of nuclear war. I agreed to do it partially because I respect Bob [Siliciano] so much, and partially because I thought the concept was excellent, said former board member Doug Richman, a prominent HIV drug researcher at the University of California San Diego and former member of the funds scientific advisory board. I disagree with his interpretation of the data regarding several medicines and strongly disagree with his anti-vaccine nonsense, Boulware wrote to me. The anecdotal data of 100% success rates is further icing on the cake. JAMA Reports Fluvoxamine as Potential Early Treatment for COVID-19 We could have saved a lot of lives. They were all given the drug soon after symptoms and the placebo group was pure in that they were not taking any COVID drugs. Fluvoxamine as a potential treatment for Covid - The External Medicine . We look for advances that will have a big impact on our lives and break down why they matter. The group who declined the drug were very sick with 12.5% requiring hospitalization and one died. During our first conversation, which turned into a multi-hour Zoom session, Kirsch paced through the rooms of his cavernous house with his phone held at chest level, rarely looking down at the camera. , a non-profit known as the nations drug pricing watchdog, did a review of the evidence and determined that fluvoxamine evidence is superior to Molnupiravir.
Valpo Volleyball Roster 2021,
Epsrc New Investigator Award Example,
Articles S